Adial Pharmaceuticals Financial Overview
Adial Pharmaceuticals's market cap is currently $7.40M. The company's EPS TTM is $-0.08; its P/E ratio is -0.33; Adial Pharmaceuticals is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
